Tags

Type your tag names separated by a space and hit enter

Effective immunization against influenza in pediatric renal transplant recipients.
Clin Transplant 1996; 10(6 Pt 1):556-60CT

Abstract

Viral infections such as influenza are an important cause of morbidity following organ transplantation. We evaluated the immunogenicity of a commercially available influenza vaccine in pediatric renal transplant recipients in a two-phase, prospective study. In phase one, 47 transplant patients and seven control subjects with bronchopulmonary dysplasia received influenza vaccine. Sera were collected at the time of vaccination and 6 wk later. In phase two, sera from 18 transplant recipients and 47 healthy adults who had received the same vaccine were collected 6-12 months after vaccination. Antibody titers to the A/Taiwan/1/86 antigen were measured with hemagglutination inhibition assay in both phases of the study. Vaccine was well tolerated in all subjects. No vaccinated patient required hospitalization for complications of influenza infection. Vaccination did not increase the frequency of acute allograft rejection. In phase one, 43 patients (91%) and 5 controls (71%) either seroconverted (developed a fourfold or greater rise in titer), or developed post-vaccination titers > or = 1:160 (p = NS). Among the transplant recipients, non-seroconverters had a higher pre-vaccination geometric mean antibody titer (GMT) than those who seroconverted. Seroconversion developed independently of whether patients received double or triple immunosuppression. In phase two, post-vaccination GMT were similar for patients and control subjects at 11.5 and 8 months post-vaccination, respectively. In our study, influenza vaccination produced equivalent humoral immunity in transplant recipients and normal subjects. Routine influenza vaccination should be performed annually in this high-risk population.

Authors+Show Affiliations

Department of Pediatrics, St. Christopher's Hospital for Children, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

8996778

Citation

Edvardsson, V O., et al. "Effective Immunization Against Influenza in Pediatric Renal Transplant Recipients." Clinical Transplantation, vol. 10, no. 6 Pt 1, 1996, pp. 556-60.
Edvardsson VO, Flynn JT, Deforest A, et al. Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant. 1996;10(6 Pt 1):556-60.
Edvardsson, V. O., Flynn, J. T., Deforest, A., Kaiser, B. A., Schulman, S. L., Bradley, A., ... Baluarte, H. J. (1996). Effective immunization against influenza in pediatric renal transplant recipients. Clinical Transplantation, 10(6 Pt 1), pp. 556-60.
Edvardsson VO, et al. Effective Immunization Against Influenza in Pediatric Renal Transplant Recipients. Clin Transplant. 1996;10(6 Pt 1):556-60. PubMed PMID: 8996778.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effective immunization against influenza in pediatric renal transplant recipients. AU - Edvardsson,V O, AU - Flynn,J T, AU - Deforest,A, AU - Kaiser,B A, AU - Schulman,S L, AU - Bradley,A, AU - Palmer,J, AU - Polinsky,M S, AU - Baluarte,H J, PY - 1996/12/1/pubmed PY - 1996/12/1/medline PY - 1996/12/1/entrez SP - 556 EP - 60 JF - Clinical transplantation JO - Clin Transplant VL - 10 IS - 6 Pt 1 N2 - Viral infections such as influenza are an important cause of morbidity following organ transplantation. We evaluated the immunogenicity of a commercially available influenza vaccine in pediatric renal transplant recipients in a two-phase, prospective study. In phase one, 47 transplant patients and seven control subjects with bronchopulmonary dysplasia received influenza vaccine. Sera were collected at the time of vaccination and 6 wk later. In phase two, sera from 18 transplant recipients and 47 healthy adults who had received the same vaccine were collected 6-12 months after vaccination. Antibody titers to the A/Taiwan/1/86 antigen were measured with hemagglutination inhibition assay in both phases of the study. Vaccine was well tolerated in all subjects. No vaccinated patient required hospitalization for complications of influenza infection. Vaccination did not increase the frequency of acute allograft rejection. In phase one, 43 patients (91%) and 5 controls (71%) either seroconverted (developed a fourfold or greater rise in titer), or developed post-vaccination titers > or = 1:160 (p = NS). Among the transplant recipients, non-seroconverters had a higher pre-vaccination geometric mean antibody titer (GMT) than those who seroconverted. Seroconversion developed independently of whether patients received double or triple immunosuppression. In phase two, post-vaccination GMT were similar for patients and control subjects at 11.5 and 8 months post-vaccination, respectively. In our study, influenza vaccination produced equivalent humoral immunity in transplant recipients and normal subjects. Routine influenza vaccination should be performed annually in this high-risk population. SN - 0902-0063 UR - https://www.unboundmedicine.com/medline/citation/8996778/Effective_immunization_against_influenza_in_pediatric_renal_transplant_recipients_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=8996778.ui DB - PRIME DP - Unbound Medicine ER -